Tech Company Financing Transactions
BioCentriq Funding Round
On 1/3/2024, BioCentriq raised $29.2 million in Series A investment from private investors.
Transaction Overview
Company Name
Announced On
1/3/2024
Transaction Type
Venture Equity
Amount
$29,200,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to enhance its facilities, invest in advanced technologies, and expand its team.
Company Information
Company Status
Private & Independent
Industry
Manufacturing
Mailing Address
138 Summit St
Newark, NJ 07103
USA
Newark, NJ 07103
USA
Phone
Website
Email Address
Overview
BioCentriq is a global cell therapy Contract Development and Manufacturing Organization (CDMO) with a proven track record successfully transferring, developing, and manufacturing GMP drug product for use in clinical trials. The Executive, Technical, and Business Development teams have commercialized four unique cell therapies and translated more than 20 programs into the clinic. This expertise, coupled with phase-appropriate quality systems and a modern infrastructure have established BioCentriq as a trusted strategic partner for the development and manufacture of autologous and allogeneic cell therapies. BioCentriq's four flexible GMP manufacturing suites are supported by fully equipped process and analytical development laboratories to ensure seamless translation from the lab to the clinic.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Park
Browse more venture capital transactions:
Prev: 1/3/2024: Full-Life Technologies venture capital transaction
Next: 1/4/2024: Arbital Health venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs